[NF-κB activity in myeloid leukemia stem cells].

Area of Science:

• Hematologic Malignancies
• Cancer Cell Biology
• Molecular Oncology

Background:

• Acute myeloid leukemia (AML) is driven by leukemia initiating cells (LICs) resistant to conventional chemotherapy.
• Identifying mechanisms of LIC maintenance is key to developing effective AML treatments.
• Constitutive NF-κB pathway activation is observed in various AML subtypes, suggesting its potential role.

Purpose of the Study:

• To investigate the role of the NF-κB pathway in maintaining leukemia initiating cells (LICs) in acute myeloid leukemia (AML).
• To elucidate the specific mechanisms driving NF-κB activity within AML LICs.
• To evaluate the therapeutic potential of targeting the NF-κB/TNF-α axis in AML.

Main Methods:

• Utilized myeloid leukemia mouse models to study NF-κB activity in LICs.
• Investigated autocrine TNF-α secretion and its role in an NF-κB positive feedback loop.
• Assessed the impact of proteasome machinery on IκBα degradation and NF-κB activation.
• Performed genetic ablation of TNF-α and NF-κB to evaluate their in vivo effects on leukemia progression.

Main Results:

• Found that NF-κB activity is specifically maintained in AML LICs via an autocrine TNF-α feedback loop.
• Observed increased active proteasome machinery in LICs, contributing to sustained NF-κB signaling through IκBα degradation.
• Demonstrated that genetic deletion of TNF-α or NF-κB significantly inhibited leukemia progression in vivo.

Conclusions:

• The NF-κB/TNF-α signaling pathway is critical for the maintenance and progression of acute myeloid leukemia by sustaining LICs.
• Targeting this specific signaling axis in LICs represents a broadly applicable therapeutic strategy for AML.